Suppr超能文献

尿转铁蛋白在糖尿病肾病中的诊断意义

Diagnostic significance of urinary transferrin in diabetic nephropathy.

作者信息

Kanauchi M, Nishioka H, Hashimoto T, Dohi K

机构信息

First Department of Internal Medicine, Nara Medical University, Japan.

出版信息

Nihon Jinzo Gakkai Shi. 1995 Nov;37(11):649-54.

PMID:8583702
Abstract

We evaluated the diagnostic utility of urinary transferrin (Tf) in patients with diabetic nephropathy by comparing the diagnostic findings with those of clinical stage and renal biopsy specimens. According to the rate of urinary albumin excretion, a total of 60 patients with non-insulin-dependent diabetes mellitus were separated into normoalbuminuria (< 28.8 mg/day), microalbuminuria (28.8 approximately 288 mg/day), and overt proteinuria (> 288 mg/day). They were also divided into 5 groups, D0, DI, DII, DIII and DIV according to the severity of glomerular diffuse lesions using Gellman's criteria. Thirty-eight non-diabetic volunteers were used as controls. Using 24-hour urine specimens, Tf was measured by latex-immuno-turbidimetry. Urinary concentrations of albumin, alpha 1-microglobulin, beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase (NAG) were also evaluated. Urinary Tf was significantly increased in the diabetic patients relative to the non-diabetic controls. The incidence of microtransferrinuria (440 approximately 4,400 micrograms/day) was 33.3% in normoalbuminuria, 63.2% in microalbuminuria, and 18.2% in overt proteinuria. The incidence of overt transferrinuria (> 4,400 micrograms/day) was 0%, 36.8% and 81.8%, respectively. Among the diabetic patients, urinary Tf showed a significant increase with respect to the progress of glomerular diffuse lesions. The glomerular diffuse lesions of 10 normoalbuminuric cases with microtransferrinuria were graded as DI in 8 cases, DII in 1 case, and DIII in 1 case. There was a significant correlation between the urinary excretion of Tf and that of albumin, alpha 1-microglobulin or NAG. The findings indicate that urinary Tf may be useful in detecting diabetic nephropathy at an early stage.

摘要

我们通过将诊断结果与临床分期及肾活检标本的结果进行比较,评估了尿转铁蛋白(Tf)在糖尿病肾病患者中的诊断效用。根据尿白蛋白排泄率,将总共60例非胰岛素依赖型糖尿病患者分为正常白蛋白尿组(<28.8毫克/天)、微量白蛋白尿组(28.8至288毫克/天)和显性蛋白尿组(>288毫克/天)。还根据Gellman标准,根据肾小球弥漫性病变的严重程度将他们分为5组,即D0、D1、D2、D3和D4。38名非糖尿病志愿者作为对照。使用24小时尿液标本,通过乳胶免疫比浊法测量Tf。还评估了尿中白蛋白、α1-微球蛋白、β2-微球蛋白和N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的浓度。与非糖尿病对照组相比,糖尿病患者的尿Tf显著升高。微量转铁蛋白尿(440至4400微克/天)的发生率在正常白蛋白尿组中为33.3%,在微量白蛋白尿组中为63.2%,在显性蛋白尿组中为18.2%。显性转铁蛋白尿(>4400微克/天)的发生率分别为0%、36.8%和81.8%。在糖尿病患者中,尿Tf随着肾小球弥漫性病变的进展而显著增加。10例有微量转铁蛋白尿的正常白蛋白尿病例的肾小球弥漫性病变,8例分级为D1,1例为D2,1例为D3。Tf的尿排泄量与白蛋白、α1-微球蛋白或NAG的尿排泄量之间存在显著相关性。这些结果表明,尿Tf可能有助于早期检测糖尿病肾病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验